Results 131 to 140 of about 10,387 (198)

The Endothelial Glycocalyx: The First Line of Defense in the Prevention and Treatment of Kidney Diseases. [PDF]

Kidney Med
Yuan X, Jia M, Zhou L, Hou G, Zhang B, Ouyang X, Huang Y.   +6 more
europepmc   +1 more source

The complement system in lipid-mediated pathologies. [PDF]

Front Immunol
Alic L, Dendinovic K, Papac-Milicevic N.
europepmc   +1 more source

Toward a monogenic architecture of human infections: From 1996 to 2026. [PDF]

J Hum Immun
Casanova JL.
europepmc   +1 more source

Immunodeficiency: Complement disorders. [PDF]

Allergy Asthma Proc
McMurray JC, Schornack BJ, Weskamp AL, Park KJ, Pollock JD, Day WG, Brockshus AT, Beakes DE, Schwartz DJ, Mikita CP, Pittman LM.   +10 more
europepmc   +1 more source

Editorial on Special Issue "State-of-Art in mRNA Therapeutics and Gene Delivery". [PDF]

Pharmaceutics
Mendonça LS.
europepmc   +1 more source

The role of complement in long COVID pathogenesis. [PDF]

JCI Insight
Bayarri-Olmos R, Bain W, Iwasaki A.
europepmc   +1 more source

Apical tubular complement activation and the loss of kidney function in proteinuric kidney diseases. [PDF]

Clin Kidney J
Alkaff FF, Lammerts RGM, Daha MR, Berger SP, van den Born J.   +4 more
europepmc   +1 more source

A percolation phase transition controls complement protein coating of surfaces. [PDF]

Cell
Wang Z, Kulkarni S, Nong J, Zamora M, Ebrahimimojarad A, Hood E, Shuvaeva T, Zaleski M, Gullipalli D, Wolfe E, Espy C, Arguiri E, Wu J, Wang Y, Marcos-Contreras OA, Song W, Muzykantov VR, Fu J, Radhakrishnan R, Myerson JW, Brenner JS.   +20 more
europepmc   +1 more source